Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KRT86 antisense RNA 1 (KRT86-AS1) is a gene that encodes a long non-coding RNA transcribed antisense to the KRT86 locus. There is extremely limited information available regarding its biological function, disease relevance, or pharmacological targeting. It does not classify as an enzyme, receptor, transporter, or other protein-coding therapeutic target. As of current knowledge, KRT86-AS1 is not recognized as a validated drug target, biomarker, or regulator in human health or disease. No aliases, interacting drugs, or actionable mechanisms are established for this lncRNA at this time[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on KRT86 antisense RNA 1 (KRT86-AS1).